CLYM · Climb Bio, Inc.
$12.11
-0.18 (-1.46%)
At close · Jul 29
Market Cap
$703.73M
Shares
57.26M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-04 | New | Biotechnology | $110,076,289 | $110,076,289 | 06b |
| 2024-07-02 | New | Biotechnology | $41,867,154 | $41,867,154 | 06b |
| 2024-07-02 | New | Biotechnology | $119,999,986 | $119,999,986 | 06b |
| 2021-05-28 | New | Pharmaceuticals | $59,999,987 | $59,999,987 | 06b |
| 2020-11-03 | New | Pharmaceuticals | $49,999,985 | $4,999,995 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1768446
CUSIP
28658R106
13F (30d)
10 filings
10 filers
Visit website
Investor relations